Published in J Biol Chem on August 25, 1989
The methionine-rich domain of the 54 kd protein subunit of the signal recognition particle contains an RNA binding site and can be crosslinked to a signal sequence. EMBO J (1990) 2.35
Novel benzodiazepine photoaffinity probe stereoselectively labels a site deep within the membrane-spanning domain of the cholecystokinin receptor. J Med Chem (2006) 0.97
The binding protein of corticotropin-releasing factor: ligand-binding site and subunit structure. Proc Natl Acad Sci U S A (2002) 0.94
Young Investigator Award Lecture. Structures of larger proteins, protein-ligand and protein-DNA complexes by multidimensional heteronuclear NMR. Protein Sci (1994) 0.88
Residue 17 of sauvagine cross-links to the first transmembrane domain of corticotropin-releasing factor receptor 1 (CRFR1). J Biol Chem (2008) 0.85
SH3 domain-based phototrapping in living cells reveals Rho family GAP signaling complexes. Sci Signal (2011) 0.84
Photolabeling evidence for calcium-induced conformational changes at the ATP binding site of scallop myosin. Proc Natl Acad Sci U S A (1993) 0.82
Structural and mechanistic basis of Parl activity and regulation. Cell Death Differ (2011) 0.80
Tyr199 in transmembrane domain 5 of the beta2-adrenergic receptor interacts directly with the pharmacophore of a unique fluorenone-based antagonist. Biochem J (2001) 0.80
Peptide array X-linking (PAX): a new peptide-protein identification approach. PLoS One (2012) 0.78
Opposing orientations of the anti-psychotic drug trifluoperazine selected by alternate conformations of M144 in calmodulin. Proteins (2015) 0.75
Preparation, characterization and biological properties of biotinylated derivatives of calmodulin. Biochem J (1991) 0.75
A thermodynamic scale for the helix-forming tendencies of the commonly occurring amino acids. Science (1990) 6.60
beta-Peptides: from structure to function. Chem Rev (2001) 4.14
How calmodulin binds its targets: sequence independent recognition of amphiphilic alpha-helices. Trends Biochem Sci (1990) 4.04
A functionally defined model for the M2 proton channel of influenza A virus suggests a mechanism for its ion selectivity. Proc Natl Acad Sci U S A (1997) 4.03
Synthetic amphiphilic peptide models for protein ion channels. Science (1988) 3.26
Characterization of a helical protein designed from first principles. Science (1988) 2.99
Asparagine-mediated self-association of a model transmembrane helix. Nat Struct Biol (2000) 2.97
Design of DNA-binding peptides based on the leucine zipper motif. Science (1990) 2.84
De novo design of catalytic proteins. Proc Natl Acad Sci U S A (2004) 2.81
Dynamics and folding of single two-stranded coiled-coil peptides studied by fluorescent energy transfer confocal microscopy. Proc Natl Acad Sci U S A (2000) 2.75
Protein design: a hierarchic approach. Science (1995) 2.73
The two-dimensional IR nonlinear spectroscopy of a cyclic penta-peptide in relation to its three-dimensional structure. Proc Natl Acad Sci U S A (1999) 2.70
Polar side chains drive the association of model transmembrane peptides. Proc Natl Acad Sci U S A (2001) 2.64
Design and synthesis of multi-haem proteins. Nature (1994) 2.59
Metal ion-dependent modulation of the dynamics of a designed protein. Science (1993) 2.48
Molecular characterization of helix-loop-helix peptides. Science (1992) 2.26
Mutagenesis of protease cleavage sites in the human immunodeficiency virus type 1 gag polyprotein. J Virol (1991) 2.23
pH-dependent tetramerization and amantadine binding of the transmembrane helix of M2 from the influenza A virus. Biochemistry (2000) 2.14
Helix-packing motifs in membrane proteins. Proc Natl Acad Sci U S A (2006) 2.13
Crystal structure of a synthetic triple-stranded alpha-helical bundle. Science (1993) 2.09
Kinetics and mechanism of hemolysis induced by melittin and by a synthetic melittin analogue. Biophys J (1982) 2.03
Total chemical synthesis of the integral membrane protein influenza A virus M2: role of its C-terminal domain in tetramer assembly. Biochemistry (1999) 2.02
Retrostructural analysis of metalloproteins: application to the design of a minimal model for diiron proteins. Proc Natl Acad Sci U S A (2000) 2.01
Membrane binding and conformational properties of peptides representing the NH2 terminus of influenza HA-2. J Biol Chem (1987) 1.89
Purification and properties of thiol beta-lactamase. A mutant of pBR322 beta-lactamase in which the active site serine has been replaced with cysteine. J Biol Chem (1984) 1.88
De novo design of helical bundles as models for understanding protein folding and function. Acc Chem Res (2000) 1.84
p-Benzoyl-L-phenylalanine, a new photoreactive amino acid. Photolabeling of calmodulin with a synthetic calmodulin-binding peptide. J Biol Chem (1986) 1.75
Oligomerization of the integrin alphaIIbbeta3: roles of the transmembrane and cytoplasmic domains. Proc Natl Acad Sci U S A (2001) 1.74
Temperature-dependent helix-coil transition of an alanine based peptide. J Am Chem Soc (2001) 1.73
Solution structure and dynamics of a de novo designed three-helix bundle protein. Proc Natl Acad Sci U S A (1999) 1.69
Cu(II) inhibition of the proton translocation machinery of the influenza A virus M2 protein. J Biol Chem (1999) 1.67
Identification of novel peptide antagonists for GPIIb/IIIa from a conformationally constrained phage peptide library. Proteins (1992) 1.63
De novo design, synthesis, and characterization of antimicrobial beta-peptides. J Am Chem Soc (2001) 1.63
Phospholipid interactions of synthetic peptides representing the N-terminus of HIV gp41. Biochemistry (1990) 1.59
The role of helix formation in the folding of a fully alpha-helical coiled coil. Proteins (1996) 1.58
Fluorescence studies of the secondary structure and orientation of a model ion channel peptide in phospholipid vesicles. Biochemistry (1992) 1.49
Time-resolved infrared study of the helix-coil transition using (13)C-labeled helical peptides. J Am Chem Soc (2001) 1.45
Design of three-dimensional domain-swapped dimers and fibrous oligomers. Proc Natl Acad Sci U S A (2001) 1.45
Crystal structure of alpha 1: implications for protein design. Science (1990) 1.44
From coiled coils to small globular proteins: design of a native-like three-helix bundle. Protein Sci (1998) 1.43
The interaction of calmodulin with amphiphilic peptides. J Biol Chem (1985) 1.43
Resistance to HIV protease inhibitors: a comparison of enzyme inhibition and antiviral potency. Biochemistry (1998) 1.43
The regulation of sequential processing of HIV-1 Gag by the viral protease. Adv Exp Med Biol (1998) 1.41
In vivo function and membrane binding properties are correlated for Escherichia coli lamB signal peptides. Science (1985) 1.40
A helical-dipole model describes the single-channel current rectification of an uncharged peptide ion channel. Proc Natl Acad Sci U S A (1994) 1.40
Recognition and characterization of calmodulin-binding sequences in peptides and proteins. Methods Enzymol (1987) 1.39
De novo design of a monomeric helical beta-peptide stabilized by electrostatic interactions. J Am Chem Soc (2001) 1.39
The role of protonation and metal chelation preferences in defining the properties of mercury-binding coiled coils. J Mol Biol (1998) 1.37
Modeling transmembrane helical oligomers. Curr Opin Struct Biol (1997) 1.36
Posttranslational modification of human T-cell growth factor. Biochem Biophys Res Commun (1983) 1.35
High-level synthesis of recombinant HIV-1 protease and the recovery of active enzyme from inclusion bodies. Gene (1990) 1.33
Membrane fusion activity of the influenza virus hemagglutinin: interaction of HA2 N-terminal peptides with phospholipid vesicles. Biochemistry (1991) 1.33
Multiple oligomeric states regulate the DNA binding of helix-loop-helix peptides. Proc Natl Acad Sci U S A (1993) 1.33
DNA-induced increase in the alpha-helical content of C/EBP and GCN4. Biochemistry (1991) 1.31
Thermodynamic analysis of a designed three-stranded coiled coil. Biochemistry (1996) 1.31
Exploration of the structural features defining the conduction properties of a synthetic ion channel. Biophys J (1999) 1.27
D(n)-symmetrical tertiary templates for the design of tubular proteins. J Mol Biol (2001) 1.27
Controlling topology and native-like behavior of de novo-designed peptides: design and characterization of antiparallel four-stranded coiled coils. Biochemistry (1996) 1.26
Native-like and structurally characterized designed alpha-helical bundles. Curr Opin Struct Biol (1995) 1.24
Determinants of the human immunodeficiency virus type 1 p15NC-RNA interaction that affect enhanced cleavage by the viral protease. J Virol (1997) 1.22
The activation state of alphavbeta 3 regulates platelet and lymphocyte adhesion to intact and thrombin-cleaved osteopontin. J Biol Chem (2000) 1.19
Stabilization of coiled-coil peptide domains by introduction of trifluoroleucine. Biochemistry (2001) 1.19
Cleavage of p15 protein in vitro by human immunodeficiency virus type 1 protease is RNA dependent. J Virol (1994) 1.18
In vitro evolution of thermodynamically stable turns. Nat Struct Biol (1996) 1.16
Toward the de novo design of a catalytically active helix bundle: a substrate-accessible carboxylate-bridged dinuclear metal center. J Am Chem Soc (2001) 1.15
Synthesis and evaluation of benzoxazinones as HIV-1 reverse transcriptase inhibitors. Analogs of Efavirenz (SUSTIVA). Bioorg Med Chem Lett (1999) 1.15
The design, synthesis, and crystallization of an alpha-helical peptide. Proteins (1986) 1.12
Centrosymmetric bilayers in the 0.75 A resolution structure of a designed alpha-helical peptide, D,L-Alpha-1. Protein Sci (1999) 1.11
Fluorescence properties of calmodulin-binding peptides reflect alpha-helical periodicity. Science (1987) 1.10
Dynamics of a de novo designed three-helix bundle protein studied by 15N, 13C, and 2H NMR relaxation methods. Biochemistry (2001) 1.10
Nonsymmetric P2/P2' cyclic urea HIV protease inhibitors. Structure-activity relationship, bioavailability, and resistance profile of monoindazole-substituted P2 analogues. J Med Chem (1998) 1.09
Nonidentical induction of the guanylate binding protein and the 56K protein by type I and type II interferons. J Interferon Res (1986) 1.09
Improved cyclic urea inhibitors of the HIV-1 protease: synthesis, potency, resistance profile, human pharmacokinetics and X-ray crystal structure of DMP 450. Chem Biol (1996) 1.06
Two models of the influenza A M2 channel domain: verification by comparison. Fold Des (1998) 1.06
Tertiary templates for the design of diiron proteins. Curr Opin Struct Biol (1999) 1.06
Hydrophobic core malleability of a de novo designed three-helix bundle protein. J Mol Biol (2001) 1.05
Synthesis and evaluation of quinoxalinones as HIV-1 reverse transcriptase inhibitors. Bioorg Med Chem Lett (2000) 1.04
Thymosin beta 10, a new analog of thymosin beta 4 in mammalian tissues. Arch Biochem Biophys (1983) 1.02
De novo design, synthesis and characterization of membrane-active peptides. Biochem Soc Trans (2001) 1.02
Analysis and design of three-stranded coiled coils and three-helix bundles. Fold Des (1998) 0.99
Synthesis and antiplatelet effects of an isoxazole series of glycoprotein IIb/IIIa antagonists. Bioorg Med Chem Lett (1998) 0.98
Thermodynamic genetics of the folding of the B1 immunoglobulin-binding domain from streptococcal protein G. Proteins (1995) 0.96
Evolution of binding affinity in a WW domain probed by phage display. Protein Sci (2000) 0.96
From synthetic coiled coils to functional proteins: automated design of a receptor for the calmodulin-binding domain of calcineurin. J Mol Biol (1998) 0.96
The design, synthesis, and characterization of tight-binding inhibitors of calmodulin. J Cell Biochem (1985) 0.96
Distribution of thymosin beta 4 in vertebrate classes. Arch Biochem Biophys (1983) 0.95
De novo design of native proteins: characterization of proteins intended to fold into antiparallel, rop-like, four-helix bundles. Biochemistry (1997) 0.95
A polar, solvent-exposed residue can be essential for native protein structure. Structure (2000) 0.94
A predicted structure of calmodulin suggests an electrostatic basis for its function. Proc Natl Acad Sci U S A (1985) 0.93
Sequence and structural homologies among type I and type II interferons. Nature (1982) 0.93
Drug design with a new transition state analog of the hydrated carbonyl: silicon-based inhibitors of the HIV protease. Chem Biol (2001) 0.92
Synthesis and evaluation of analogs of Efavirenz (SUSTIVA) as HIV-1 reverse transcriptase inhibitors. Bioorg Med Chem Lett (1999) 0.92
Agonist-activated alphavbeta3 on platelets and lymphocytes binds to the matrix protein osteopontin. J Biol Chem (1997) 0.91
A pharmacokinetic evaluation of HIV protease inhibitors, cyclic ureas, in rats and dogs. Biopharm Drug Dispos (1994) 0.90
Compartmentation of mitochondrial creatine phosphokinase. I. Direct demonstration of compartmentation with the use of labeled precursors. J Biol Chem (1982) 0.87
Compartmentation of mitochondrial creatine phosphokinase. II. The importance of the outer mitochondrial membrane for mitochondrial compartmentation. J Biol Chem (1982) 0.87
Predicted calmodulin-binding sequence in the gamma subunit of phosphorylase b kinase. Proteins (1987) 0.86